Robert Weinstein to Cost-Benefit Analysis
This is a "connection" page, showing publications Robert Weinstein has written about Cost-Benefit Analysis.
Connection Strength
0.691
-
Making sense of universal screening for MRSA. Lancet Infect Dis. 2016 Mar; 16(3):272-3.
Score: 0.498
-
A guide to interpreting economic studies in infectious diseases. Clin Microbiol Infect. 2010 Dec; 16(12):1713-20.
Score: 0.088
-
Corrections to table. Arch Intern Med. 2004 Mar 08; 164(5):573.
Score: 0.055
-
Pneumococcal vaccination: analysis of opportunities in an inner-city hospital. Arch Intern Med. 2002 Sep 23; 162(17):1961-5.
Score: 0.050